Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility

Journal of Clinical Investigation

Volumn 104, Issue 9, 1999, Pages 1223-1233

  Wiest, R ^a   Das, S ^a   Cadelina, G ^a   Garcia Tsao, G ^a,b   Milstien, S ^c   Groszmann, Roberto J ^a,b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; METHOXAMINE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TETRAHYDROBIOPTERIN; TUMOR NECROSIS FACTOR ALPHA; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENDOTHELIUM; ENZYME ACTIVITY; ENZYME INDUCTION; LIVER CIRRHOSIS; MALE; MESENTERY BLOOD VESSEL; MESENTERY LYMPH NODE; MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; RAT; SHEAR STRESS; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0032696338     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7458     Document Type: Article

References (75)

1. Colombato, L.A., Albillos, A., and Groszmann, R.J. 1992. Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portal-hypertensive rats. Hepatology. 15:323-328.
2. Groszmann, R.J. 1994. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology. 20:1359-1363.
3. Schrier, R.W., et al. 1988. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 8:1151-1157.
4. Atucha, N.M., Shah, V., Garcia-Cardena, G., Sessa, W.E., and Groszmann, R.J. 1996. Role of endothelium in the abnormal response of mesenteric vessels in rats with portal hypertension and liver cirrhosis. Gastroenterology. 111:1627-1632.
5. Sieber, C.C., Lopez-Talavera, J.C., and Groszmann, R.J. 1993. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology. 104:1750-1754.
6. Sieber, C.C., and Groszmann, R.J. 1992. In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade. Am. J. Physiol. 262:G996-G1001.
7. Sieber, C.C., and Groszmann, R.J. 1992. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats, Gastroenterology. 103:235-239.
8. Murray, B.M., and Paller, M.S. 1985. Decreased pressor reactivity to angiotensin II in cirrhotic rats. Evidence for a post-receptor defect in angiotensin action. Circ. Res. 57:424-431.
9. Kiel, J.W., Pitts, V., Benoit, J.N., Granger, D.N., and Shepherd, A.P. 1985. Reduced vascular sensitivity to norepinephrine in portal-hypertensive rats. Am. J. Physiol. 248:G192-G195.
10. Lee, F.Y., Albillos, A., Colombato, L.A., and Groszmann, R.J. 1992. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats. Hepatology. 16:1043-1048.
11. Castro, A., et al. 1993. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide. Hepatology. 18:367-372.
12. Cahill, P.A., Redmond, E.M., Hodges, R., Zhang, S., and Sitzmann, J.V. 1996. Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats. J. Hepatol. 25:370-378.
13. Gadano, A.C., et al. 1997. Endothelial calcium-calmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivity of portal hypertensive rats. J. Hepatol. 26:678-686.
14. Martin, P.Y., et al. 1996. Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats. Am. J. Physiol. 270:F494-F499.
15. Niederberger, M., et al. 1996. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis vs. prehepatic portal hypertension in rats. Hepatology. 24:947-951.
16. Hori, N., Wiest, R., and Groszmann, R.J. 1998. Enhanced release of nitric oxide in response to changes in flow and shear stress in the superior mesenteric arteries of portal hypertensive rats. Hepatology. 28:1467-1473.
17. Wiest, R., Shah, V., Sessa, W.C., and Groszmann, R.J. 1999. Nitric oxide overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. Am. J. Physiol. 276:G1043-G1051.
18. Szabo, C., Mitchell, J.A., Thiemermann, C., and Vane, J.R. 1993. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br. J. Pharmacol. 108:786-792.
19. Meyer, J., et al. 1994. Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. Crit. Care Med. 22:306-312.
20. Tracey, W.R., Tse, J., and Carter, G. 1995. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J. Pharmacol. Exp. Ther. 272:1011-1015.
21. Guarner, C., et al. 1993. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology. 18:1139-1143.
22. Lee, F.Y., et al. 1996. Role of endotoxaemia in hyperdynamic circulation in rats with extrahepatic or intrahepatic portal hypertension. J. Gastroenterol. Hepatol. 11:152-158.
23. Lin, R.S., et al. 1995. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J. Hepatol. 22:165-172.
24. Lumsden, A.B., Henderson, J.M., and Kutner, M.H. 1988. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology. 8:232-236.
25. Vallance, P. and Moncada, S. 1991. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet. 337:776-778.
26. Berg, R.D. 1992. Translocation and the indigenous gut flora. In Probiotics. R. Fuller, editor. Chapman Hall. London, United Kingdom. 55-85.
27. Wells, C.L., Maddaus, M.A., and Simmons, R.L. 1988. Proposed mechanisms for the translocation of intestinal bacteria. Rev. Infect. Dis. 10:958-979.
28. Guarner, C., Runyon, B.A., Young, S., Heck, M., and Sheikh, M.Y. 1997. Intestinal bacterial overgrowth and bacterial translocarion in cirrhotic rats with ascites. J. Hepatol. 26:1372-1378.
29. Garcia-Tsao, G., Albillos, A., Barden, G.E., and West, A.B. 1993. Bacterial translocation in acute and chronic portal hypertension. Hepatology. 17:1081-1085.
30. Alexander, J.W., et al. 1990. The process of microbial translocation. Ann. Surg. 212:496-510.
31. Wyke, R.J. 1987. Problems of bacterial infection in patients with liver disease. Gut. 28:623-641.
32. Popper, H., and Paronetto, F. 1984. Problems in the immunology of hepatic diseases. Hepatogastroenterology. 31:1-5.
33. Garcia-Tsao, G., Lee, F.Y., Barden, G.E., Cartun, R., and West, A.B. 1995. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology. 108:1835-1841.
34. Runyon, B.A., Squier, S., and Borzio, M. 1994. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J. Hepatol. 21:792-796.
35. Llovet, J.M., et al. 1994. Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis. Gut. 35:1648-1652.
36. Casafont, F., Sanchez, E., Martin, L., Aguero, J., and Romero, F.P. 1997. Influence of malnutrition on the prevalence of bacterial translocation and spontaneous bacterial peritonitis in experimental cirrhosis in rats. Hepatology. 25:1334-1337.
37. O'Boyle, C.J., et al. 1998. Microbiology of bacterial translocation in humans. Gut. 42:29-35.
38. Runyon, B.A., et al. 1995. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis. Hepatology. 21:1719-1724.
39. Llovet, J.M., et al. 1998. Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence. J. Hepotol. 28:307-313.
40. Old, L.J. 1985. Tumor necrosis factor (TNF). Science. 230:630-632.
41. Tilg, H., et al. 1992. Serum levels of cytokines in chronic liver diseases. Gastroenterology. 103:264-274.
42. Lopez-Talavera, J.C., Cadelina, G., Olchowski, J., Merrill, W., and Groszmann, R.J. 1996. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats. Hepatology. 23:1616-1621.
43. Chu, C.J., et al. 1997. Hyperdynamic circulation of cirrhotic rats with ascites: role of endotoxin, tumour necrosis factor and nitric oxide. Clin. Sci. (Colch.) 93:219-225.
44. Ohta, M., et al. 1998. Does tumor necrosis factor alpha regulate nitric oxide synthase expression in the portal hypertensive gastric mucosa? Gastroenterology. 112:A1351. (Abstr.)
45. Lopez-Talavera, J.C., Merrill, W.W., and Groszmann, R.J. 1995. Tumor necrosis factor alpha: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterotogy. 108:761-767.
46. Mainous, M.R., Ertel, W., Chaudry, I.H., and Deitch, E.A. 1995. The gut: a cytokine-generating organ in systemic inflammation? Shock. 4:193-199.
47. Deitch, E.A., Xu, D., Franko, L., Ayala, A., and Chaudry, I.H. 1994. Evidence favoring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock. Shock. 1:141-145.
48. McGregor, D.D. 1965. The effect of sympathetic nerve stimulation on vasoconstrictor responses in perfused mesenteric vessels of the rat. J. Physiol. (Lond.) 177:21-30.
49. Tsutsui, M., Milstien, S., and Katusic, Z.S. 1996. Effect of tetrahydrobiopterin on endothelial function in canine middle cerebral arteries. Circ. Res. 79:336-342.
50. Moncada, S. 1997. Nitric oxide in the vasculature: physiology and pathophysiology. Ann. NY Acad. Sci. 811:60-67; discussion 67-69.
51. Sessa, W.C. 1994. The nitric oxide synthase family of proteins. J. Vasc. Res. 31:131-143.
52. Moncada, S., Palmer, R.M., and Higgs, E.A. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
53. Buga, G.M., Gold, M.E., Fukuto, J.M., and Ignarro, L.J. 1991. Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension. 17:187-193.
54. Rubanyi, G.M., Romero, J.C., and Vanhoutte, P.M. 1986. Flow-induced release of endothelium-derived relaxing factor. Am. J. Physiol. 250:H1145-H1149.
55. Weigert, A.L., et al. 1995. Endothelium-dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats. Hepatology. 22:1856-1862.
56. Ortiz, M.C., et al. 1996. Vascular hyporesponsiveness in aortic rings from cirrhotic rats: role of nitric oxide and endothelium. Clin. Sci. (Colch.) 91:733-738.
57. Tsoporis, J., Fields, N., Lee, R.M., and Leenen, F.H. 1991. Arterial vasodilation and cardiovascular structural changes in normotensive rats. Am. J. Physiol. 260:H1944-H1952.
58. Sumanovski, L.T., Battegay, E., Stumm, M., Kooij, M., and Sieber, C.C. 1999. Increased mesenteric angiogenesis in portal hypertensive rats: role of nitric oxide. Hepatology. 29:1044-1049.
59. Takahashi, M., Ishida, T., Traub, O., Corson, M.A., and Berk, B.C. 1997. Mechanotransduction in endothelial cells: temporal signaling events in response to shear stress. J. Vasc. Res. 34:212-219.
60. Cooke, J.P., Rossitch, E., Jr., Andon, N.A., Loscalzo, J., and Dzau, V.J. 1991. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J. Clin. Invest. 88:1663-1671.
61. Heinemann, A., and Stauber, R.E. 1995. The role of inducible nitric oxide synthase in vascular hyporeactivity of endotoxin-treated and portal hypertensive rats. Eur. J. Pharmacol. 278:87-90.
62. Sogni, P., Smith, A.P., Gadano, A., Lebrec, D., and Higenbottam, T.W. 1997. Induction of nitric oxide synthase II does not account for excess vascular nitric oxide production in experimental cirrhosis. J. Hepatol. 26:1120-1127.
63. Fernandez, M., et al. 1995. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats. Gastroenterology. 108:1487-1495.
64. Llach, J., et al. 1988. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology. 94:482-487.
65. Wells, C.L., Maddaus, M.A., and Simmons, R.L. 1987. Role of the macrophage in the translocation of intestinal bacteria. Arch. Surg. 122:48-53.
66. Aranow, J.S., and Fink, M.P. 1996. Determinants of intestinal barrier failure in critical illness. Br. J. Anaesth. 77:71-81.
67. Gross, S.S., Jaffe, E.A., Levi, R., and Kilbourn, R.G. 1991. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase that is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages. Biochem. Biophys. Res. Commun. 178:823-829.
68. Werner, E.R., Werner-Felmayer, G., Wachter, H., and Mayer, B. 1996. Biosynthesis of nitric oxide: dependence on pteridine metabolism. Rev. Physiol. Biochem. Pharmacol. 127:97-135.
69. Stroess, E., et al. 1997. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J. Clin. Invest. 99:41-46.
70. Wever, R.M.F., Van Dam, T., Van Rijn, H.J.M., DeGroot, F., and Rabelink, T.J. 1997. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem. Biophys. Res. Commun. 237:340-344.
71. Werner, E.R., Werner-Felmayer, G., and Wachter, H. 1993. Tetrahydrobiopterin and cytokines. Proc. Soc. Exp. Biol. Med. 203:1-12.
72. Werner-Felmayer, G., et al. 1993. Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. J. Biol. Chem. 268:1842-1846.
73. Rosenkranz-Weiss, P., et al. 1994. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J. Clin. Invest. 93:2236-2243.
74. Katusic, Z.S., Stelter, A., and Milstien, S. 1998. Cytokines stimulate GTP cyclohydrolase I gene expression in cultured human umbilical vein endothelial cells. Arterioscler. Thromb. Vasc. Biol. 18:27-32.
75. Bhagat, K., and Vallance, P.J. 1997. Induction of nitric oxide synthase in humans, in vivo: endothelial nitric oxide synthase masquerading as inducible nitric oxide synthase. Circulation. 96:A4069.(Abstr.)